Chronic Inflammatory Demyelinating Polyradiculoneuropathy Clinical Trial
Official title:
Magnetic Resonance Imaging and Ultrasound Imaging of Peripheral Nerves in Patients Treated With Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
We want to study whether MRI can be useful in diagnosing and monitoring patients with CIDP in maintenance treatment with immunoglobulin
Chronic inflammatory neuropathies such as chronic inflammatory demyelinating
polyradiculoneuropathy (CIDP) can be successfully treated with immunoglobulin either
intravenously (IVIG) or subcutaneously (SCIG).
CIDP is diagnosed by electrophysiology which is time-consuming and unpleasant for the
patient.
New techniques suggest that Magnetic Resonance Imaging (MRI) and ultrasound imaging can be
used to detect injuries in the peripheral nerves
We want to study if MRI and ultrasound is able to detect damages in peripheral nerves, nerve
roots and plexus in patients with CIDP.
Moreover, we want to compare these findings to healthy matched controls and to see if
treatment with immunoglobulin changes findings in MRI
;
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04356781 -
Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing
|
||
| Recruiting |
NCT04561557 -
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
|
Early Phase 1 | |
| Terminated |
NCT01225276 -
Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP
|
Phase 2/Phase 3 | |
| Completed |
NCT02892890 -
Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin
|
N/A | |
| Active, not recruiting |
NCT03584022 -
Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial
|
N/A | |
| Terminated |
NCT02317562 -
Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302
|
Phase 3 | |
| Recruiting |
NCT06325878 -
Genetic Architecture of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
|
N/A | |
| Recruiting |
NCT06290128 -
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
|
Phase 3 | |
| Completed |
NCT02293460 -
Efficacy and Safety Study of I10E in Treatment of Patients With CIDP
|
Phase 3 | |
| Withdrawn |
NCT05257733 -
Evaluation of the Diagnostic Contributions of Nerve Ultrasound in Chronic Inflammatory Demyelinating Polyneuropathy Associating Systemic Diseases (CIDP Echo-nerf)
|
||
| Completed |
NCT03967899 -
Study of Electrical Prognostic Factors of Response to Intravenous Immunoglobulin Treatment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
|
||
| Not yet recruiting |
NCT04978623 -
Role of High Frequency Ultrasound in Demyelinating Polyneuropathies
|
||
| Active, not recruiting |
NCT02404298 -
Transcriptome Analysis of the Peripheral Blood in CIDP
|
N/A | |
| Completed |
NCT00099489 -
Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
|
Phase 2 | |
| Completed |
NCT01625182 -
Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
|
Phase 3 | |
| Completed |
NCT02549170 -
A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
|
Phase 3 | |
| Completed |
NCT02955355 -
Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP
|
Phase 3 | |
| Active, not recruiting |
NCT04658472 -
Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
|
Phase 2 | |
| Withdrawn |
NCT04529291 -
InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
|
N/A |